[Elsevier] Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial |
|
This post will be closed automatically in 2026-08-02 03:34
Reward10points
|
| |
post
reply
points
810
10
Fermented foods and probiotic claims: A critical review of scientific validation and regulatory standards
50
[Full book]Emerging Trends in Energy Storage Systems and Industrial Applications
10
Resting-state functional connectivity of the rostral and dorsal anterior cingulate cortex in older bereaved adults
10
An inverted F-shaped slotted broadband metasurface-based circularly polarized patch antenna for 5G application
10
A critical review on recent progress on nanostructured polyaniline (PANI) based sensors for various toxic gases: Challenges, applications, and future prospects